Search Results - "Fogel, Ron"
-
1
-
2
-
3
Tu1945 Clinical Response to Anti-MMP9 Antibody (GS-5745) is Accompanied by Histologic Improvement in Ulcerative Colitis
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2016)Get full text
Journal Article -
4
Sa1395 Nexvax2®, a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+ People With Celiac Disease (CeD)
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2016)Get full text
Journal Article -
5
Sa1396 A Single Intradermal (ID) Injection of Nexvax2®, a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+ T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+ People With Celiac Disease (CeD)
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2016)Get full text
Journal Article -
6
925g Plecanatide, a Novel Guanylate Cyclase-C (GC-C) Receptor Agonist, is Efficacious and Safe in Patients with Chronic Idiopathic Constipation (CIC): Results from a 951 Patient, 12 Week, Multi-Center Trial
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2013)Get full text
Journal Article